ARCELLX INC's ticker is and the CUSIP is 03940C100. A total of 140 filers reported holding ARCELLX INC in Q2 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $965,462 | – | 31,336 | – | 0.12% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SR ONE CAPITAL MANAGEMENT, LP | 5,500,007 | $169,455,216 | 63.12% |
NEA Management Company, LLC | 4,745,262 | $146,201,522 | 10.11% |
Samsara BioCapital, LLC | 909,579 | $28,024,129 | 5.79% |
Paradigm Biocapital Advisors LP | 1,757,779 | $54,157,171 | 5.13% |
Soleus Capital Management, L.P. | 1,248,147 | $38,455,409 | 3.98% |
Perceptive Advisors | 3,841,739 | $118,363,979 | 3.50% |
Cormorant Asset Management, LP | 1,600,000 | $49,296 | 3.25% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 2,398,321 | $73,892,270 | 3.12% |
Altium Capital Management LP | 150,000 | $4,621,500 | 2.56% |
Novo Holdings A/S | 1,225,000 | $37,742,250 | 2.49% |